Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic bronchopulmonary aspergillosis.

J N Fink

    Chest
    |January 1, 1985
    PubMed
    Summary

    Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder complicating asthma, marked by specific symptoms and antibodies. Early treatment with corticosteroids is crucial to prevent severe lung damage like fibrosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Molecular biology and immunology of fungal allergens.

    Indian journal of clinical biochemistry : IJCB·2012
    Same author

    The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.

    Clinical and experimental immunology·2005
    Same author

    Detection of focal cerebral hemisphere lesions using the neurological examination.

    Journal of neurology, neurosurgery, and psychiatry·2005
    Same author

    Therapy of allergic bronchopulmonary aspergillosis.

    The Indian journal of chest diseases & allied sciences·2004
    Same author

    Molecular characterization of aspergillus fumigatus allergens.

    The Indian journal of chest diseases & allied sciences·2004
    Same author

    Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility.

    Neurology·2001

    Area of Science:

    • Pulmonology
    • Immunology
    • Infectious Diseases

    Background:

    • Allergic bronchopulmonary aspergillosis (ABPA) is a significant complication in asthma patients.
    • It manifests as an infiltrative lung disorder with diverse clinical presentations.

    Purpose of the Study:

    • To describe the key features of ABPA.
    • To highlight diagnostic markers and potential long-term consequences.
    • To outline current therapeutic strategies.

    Main Methods:

    • Clinical presentation review.
    • Serological marker analysis (IgE, antibodies).
    • Diagnostic considerations including sputum culture limitations.

    Main Results:

    • ABPA presents with respiratory/systemic symptoms, eosinophilia, and specific antibodies to Aspergillus fumigatus.
    • Elevated total serum IgE is a key indicator.
    • Sputum cultures may not consistently detect Aspergillus fumigatus.

    Conclusions:

    • ABPA requires prompt recognition due to its potential to cause bronchiectasis and pulmonary fibrosis.
    • Corticosteroids are the primary treatment modality.

    Related Experiment Videos